drugset / Trial / NCT01115179

Propofol and Perioperative Inflammation

NCT01115179

Phase 4 Completed 79 enrolled University Hospital, Geneva
RandomizedParallel-groupTriple-blind

Summary

The inflammatory properties of propofol are still under debate. Apolipoprotein A-I (Apo A-I) is involved in the inflammatory process. This study was designed to determine whether and how propofol or its solvent modulate Apo A-I and the inflammatory response after surgical stress. The investigators study hypothesis was that propofol might modify the Apo A-I blood levels, and thus, modulate the postoperative inflammatory course.

Timeline

Start
2005-03
Primary completion
2005-12
Completion
2005-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Intralipid Other / unclassified 10 %
Comparator Propofol Small molecule 3 ug/ml
Comparator Propofol Small molecule 5 ug/ml

Indications

No indication recorded.